Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of Asthma Exacerbation Rate in Children by Non-invasive Monitoring of Inflammatory Markers in Exhaled Breath (Condensate): the RASTER Study

NCT01239238 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT01239238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01239238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of Asthma Exacerbation Rate in Children by Non-invasive Monitoring of Inflammatory Markers in Exhaled Breath (Condensate): the RASTER Study
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2013
Enrollment
102 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, children, exhaled breath condensate, home monitoring, non-invasive inflammatory markers, volatile organic compounds